PRKAA1 and metabolic dysfunction-associated steatotic liver disease: This metabolic regulation is particularly significant in the context of NAFLD, as it involves the activation of AMPK, sirtuin 1 (SIRT1), and peroxisome proliferator-activated receptor-α (PPAR-α) signaling pathways (83, 86, 87).